This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Eli Lilly and Company. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Eugene Kopach: Innovator in Dual Agonist Development
Introduction
Michael Eugene Kopach is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments.
Latest Patents
Kopach holds a patent for a "Process for Preparing a GIP/GLP1 Dual Agonist." This invention represents a crucial advancement in the treatment of metabolic diseases, showcasing his expertise and dedication to improving patient outcomes.
Career Highlights
Currently, Michael Eugene Kopach is employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to focus on groundbreaking research and development in the pharmaceutical sector.
Collaborations
Throughout his career, Kopach has collaborated with talented professionals, including Michael Oliver Frederick and Sergey Vladimirovich Tsukanov. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Michael Eugene Kopach's contributions to the field of pharmaceuticals, particularly through his patent for a dual agonist, highlight his role as an influential inventor. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile